rome buathong , md., mih., fetp. wanna hanshoaworakul , md. msc . michael o’reilly, md., mph
DESCRIPTION
Outbreak of Fatal Cardiopulmonary Failure among Children Caused by an Emerging Strain of Enterovirus 71 - Nakhorn Ratchasima Province, Thailand, 2006. Rome Buathong , MD., MIH., FETP. Wanna Hanshoaworakul , MD. MSc . Michael O’Reilly, MD., MPH. Kumnuan Ungchusak , MD., MPH. - PowerPoint PPT PresentationTRANSCRIPT
11
Outbreak of Fatal Cardiopulmonary Outbreak of Fatal Cardiopulmonary Failure among ChildrenFailure among Children
Caused by an Emerging Strain of Caused by an Emerging Strain of Enterovirus 71 - NakhornEnterovirus 71 - Nakhorn
Ratchasima Province, Thailand, 2006Ratchasima Province, Thailand, 2006
Rome Buathong, MD., MIH., FETP.Rome Buathong, MD., MIH., FETP.Wanna Hanshoaworakul, MD. MSc.Wanna Hanshoaworakul, MD. MSc.
Michael O’Reilly, MD., MPH.Michael O’Reilly, MD., MPH.Kumnuan Ungchusak, MD., MPH.Kumnuan Ungchusak, MD., MPH.
Bureau of Epidemiology Bureau of Epidemiology Ministry of Public HealthMinistry of Public Health
22
EnterovirusesFamily PicornaviridaeSmall particle size (20-30 nm) & stableResistant to pH & temperature change, lipid Solvents & detergentsSingle-stranded RNA GenomeTransmission: mainly fecal-oral route and respiratory droplets
33
Classification of Human Enteroviruses
Poliovirus Types 1, 2, 3Poliovirus Types 1, 2, 3Coxsackievirus A Types 1- 24Coxsackievirus A Types 1- 24Coxsackievirus B Types 1- 6Coxsackievirus B Types 1- 6Echovirus Types 1-3 4Echovirus Types 1-3 4Enterovirus Types 68 - 71Enterovirus Types 68 - 71
44
Clinical Manifestations of EV71Clinical Manifestations of EV71Asymptomatic Febrile illness URI
HFMD, Herpangina
Meningitis/Encephalitis/AFP
Myocarditis/Pericarditis
Pneumonia
Diarrhea/Gastroenteritis
Myopathy Pulmonary edema/ hemorrhage
Enterovirus 71
55
Etiological Agent of HFMDEtiological Agent of HFMD
HFMD
CoX A(24 spp)
CoX B(6 spp)
Echo(34 spp)
EV68-71(4 spp)
Total 68 spp.
66
BackgroundBackground
July 4th, 2006: Nakhorn Rachasima health officer reported 4 unexplained sudden deaths among young children in 3 days. An attending clinician primarily suspected myocarditis as the cause of deathThe BoE promptly started an investigation
77
ObjectivesObjectivesTo identify the cause of death for these 4 To identify the cause of death for these 4 children children To define the scope of the epidemic by To define the scope of the epidemic by active case findingactive case findingTo describe clinical characteristics of the To describe clinical characteristics of the fatal casesfatal casesTo rapidly implement control and To rapidly implement control and prevention measure prevention measure
88
Descriptive StudyDescriptive Study
Fatal cases: Fatal cases: – Reviewed medical recordsReviewed medical records– Interviewed parents of fatal casesInterviewed parents of fatal cases– Interviewed medical staffInterviewed medical staff
Non fatal cases: Non fatal cases: – Active case finding (screening) in affected Active case finding (screening) in affected
communities: Districts A and Bcommunities: Districts A and B
99
Laboratory InvestigationLaboratory Investigation
• Viral isolation Viral isolation
• Paired sera for micro-nuetralization Paired sera for micro-nuetralization antibody of EV71antibody of EV71
• Nucleotide sequencing Nucleotide sequencing
• Electron Microscopy Electron Microscopy
1010
Case DefinitionsCase DefinitionsSuspect CaseSuspect Case:: Any child < 15 years old, living in the Any child < 15 years old, living in the
same village where a fatal case occurred, who had same village where a fatal case occurred, who had one or both of the following: one or both of the following:
Fever (history or T > 37.8 C) Fever (history or T > 37.8 C) or or
Any lesion on buccal mucosa, hands or feetAny lesion on buccal mucosa, hands or feet Period: June – August 2006Period: June – August 2006
Probable CaseProbable Case:: Met suspect case criteria and died Met suspect case criteria and died without confirmatory testingwithout confirmatory testing
Confirmed CaseConfirmed Case:: Met the inclusion criteria with Met the inclusion criteria with laboratory confirmation for any Enterovirus specieslaboratory confirmation for any Enterovirus species
1111
Results
1212
CharacteristicsCharacteristics Case 1Case 1 Case 2Case 2 Case 3Case 3 Case 4Case 4GenderGender FemaleFemale MaleMale MaleMale MaleMale
Age (months)Age (months) 44 2424 1717 3939
VillageVillageDistrictDistrict
XXAA
XXAA
YYBB
ZZBB
Epidemiological Epidemiological linkage linkage Close contactClose contact NoneNone NoneNone
Onset DateOnset Date June June 2525thth
June June 2323rdrd
June June 2222ndnd
June June 2424thth
Duration of illness Duration of illness until death (days)until death (days) 44 33 33 44
Demographic Characteristics of Four Fatal Cases, Thailand , 2006
1313
Clinical Clinical Case 1Case 1 Case 2Case 2 Case 3Case 3 Case 4Case 4 FFeverever > 39 > 39 ooCC PresentPresent PresentPresent PresentPresent PresentPresent Fever duration Fever duration (days)(days) 33 33 22 33
URI symptomsURI symptoms GI symptomsGI symptoms
NoNoNoNo
NoNoNoNo
NoNoNoNo
YesYesYesYes
Acute DyspneaAcute Dyspnea PresentPresent PresentPresent PresentPresent PresentPresent Hand, foot, oral Hand, foot, oral lesionslesions
NoNo NoNo No No NoNo
TachycardiaTachycardia (HR > 200)(HR > 200)
PresentPresent PresentPresent PresentPresent PresentPresent
Clinical Manifestations among Four fatal Cases, Thailand 2006
1414
Lab/ImagingLab/Imaging Case 1Case 1 Case 2Case 2 Case 3Case 3 Case 4Case 4
EKG EKG Sinus Sinus TachycardiaTachycardia
Atrial Atrial TachycardiaTachycardia
Sinus Sinus TachycardiaTachycardia
Supravent. Supravent. TachycardiaTachycardia
WBCWBC 16,00016,000 15,30015,300 33,20033,200 22,50022,500
NeutrophilsNeutrophils 68%68% 60%60% 82%82% 72%72%
Serum glucoseSerum glucose(mg/dL)(mg/dL) > 500> 500 200-578200-578 153-408153-408 166-354166-354
Cardiac Cardiac EnzymesEnzymes ElevatedElevated Not DoneNot Done ElevatedElevated ElevatedElevated
Ejection FractionEjection Fraction 20 %20 % Not DoneNot Done 68 %68 % 10 %10 %
CXRCXR Pulmonary Pulmonary EdemaEdema
Pulmonary Pulmonary EdemaEdema
Pulmonary Pulmonary EdemaEdema
Pulmonary Pulmonary EdemaEdema
Laboratory and Imaging Results among Four Fatal Cases, Thailand 2006
1515
Chest X-Ray, Case 2Chest X-Ray, Case 2Bilateral Pulmonary Edema
No Cardiomegaly
Non - Cardiogenic Pulmonary Edema
1616
Autopsy Findings: Case 1Autopsy Findings: Case 1• Brain: diffuse brain edema; small numbers of
lymphocytes and histiocytes in the subarachnoid space; scattered foci of necrosis in the thalamus, pons and medullathalamus, pons and medulla
• Heart: diffuse congestion; no pericarditis, myocarditis or endocarditis; no infarct
• Lungs: diffuse pulmonary edema & hemorrhage; small numbers of neutrophiles and lymphocytess present in the interstitium of alveolar septa
1717
Formalin-fixed Brain Tissue
Viral-like particles, 20 nm in average diameter, non-enveloped, cytoplasm
1818
Nucleotide SequencingNucleotide Sequencing
EV71 in Case 2 identified into EV71 in Case 2 identified into Genogroup C4 Genogroup C4 Nearest strain to the isolate was Nearest strain to the isolate was Shzh01-8 (nucleotide homology: 95.8%)Shzh01-8 (nucleotide homology: 95.8%) This strain had not previously been This strain had not previously been identified in Thailand identified in Thailand
19
N5202-TW-98
2286-TX-97
6F/AUS/6/99
2641-AUS-95
S11051/SAR/98 S18191/SAR/02
1117-MA
A-98
S40221/SAR/00
0948-MAA-00
SB9564-SAR-03
5026-SIN-02
03784-MAA-97 1M/AUS/12/00
shzh03-105
shzh01-8
shzh04-J41
SHH02-6
shzh03-58
TW-0
0
SB2864
/SAR/00
2027/SIN/01
CN04104/SAR/00
5511/SIN/00
18/Sin/97
N7008-TW-99 N5101-TW-98
MY104/9/SAR/97
3799/SIN/98 7673-CT-87 2222-IA-88 2258-CA-79
2609-AUS-74
AB204852 AB204853
U22521
0.01
100100
100
99.9
TH_SI 01/06
KOR-00KOR-00
KOR-00
73.6
98.5
100
100100
91.8
78.6
100
73.3
TW-0
0
TH_SI 08/01 TH_SI 06/01
A
B1
B2B3
B4
C4
C1
C2
C3
Case 2
Courtesy of Puthawathana P.
Previously
Previously
200.01
shzh02-40
shzh03-106
AFP9811134
shzh01-8
shzh04-J39
H26-CHN-00
SHH02-17
Seksan-THAI VP197-56-CHN-
F2-CHN-00
shzh04-3
shzh03-58
shzh04-12
E20051733-
E2004104-T
ZJ-CHN-3-0
shzh04-38
EV71-CQ03-
SHH02-6
638-Yamaga
2779-Yamag
1530-Yamag
C4 Subgenogroup
Courtesy of Puthawathana P.
2121
Active Case FindingActive Case Finding• 38 non-fatal cases detected.38 non-fatal cases detected.• Age: all cases < 10 years; median age Age: all cases < 10 years; median age
24 months (3 – 120 months).24 months (3 – 120 months).• Male : Female Ratio = 1:1 (19:19)Male : Female Ratio = 1:1 (19:19)• Clinical manifestationsClinical manifestations
HFMD: 12
Herpangina:1
Febrile: 25
2222
Viral Isolation ResultsViral Isolation ResultsClinicalClinical Number Number
of Caseof Case EV71EV71 COX B & COX B & Other EVOther EV
HFMDHFMD 1212 33 11
HerpanginaHerpangina 11 00 11
Febrile Febrile IllnessIllness 2525 55 22
FatalFatal 44 22 00
TotalTotal 4242 1010 44
2323
Number of Cases by Onset of Cases Number of Cases by Onset of Cases in District A and B, Jun – Aug, 2007in District A and B, Jun – Aug, 2007
0
1
2
3
4
5
6
6/1/
2006
6/8/
2006
6/15
/200
6
6/22
/200
6
6/29
/200
6
7/6/
2006
7/13
/200
6
7/20
/200
6
7/27
/200
6
8/3/
2006
Onset
Num
ber
SuspectedConfirmrd non EV71Confirmed EV71
/-------------------Jun------------------------/ -------------------------Jul---------------------/--Aug-->
N = 42Fatal cases = 4Non-fatal cases = 38
2424
ConclusionConclusion
• EtiologyEtiology: Enterovirus 71 (Genogroup C4): Enterovirus 71 (Genogroup C4)• Cause of DeathCause of Death: Brain stem encephalitis, : Brain stem encephalitis,
+/- Myocarditis, pulmonay edema and +/- Myocarditis, pulmonay edema and hemorrhage, respiratory failurehemorrhage, respiratory failure
• StrainStrain: Emerging strain: Emerging strain• High Case Fatality ProportionHigh Case Fatality Proportion: 9.5%: 9.5%
2525
DiscussionDiscussion• Previous reports of fatalities associated with EV Previous reports of fatalities associated with EV
71 outbreaks in East Asia have occurred in the 71 outbreaks in East Asia have occurred in the context of large (thousands, tens of thousands) context of large (thousands, tens of thousands) HFMD outbreaks and low CFRs. HFMD outbreaks and low CFRs.
• In this outbreak, CFR was high (9.5%) and fatal In this outbreak, CFR was high (9.5%) and fatal cases did not manifest classic HFM signs.cases did not manifest classic HFM signs.
• This is a new epidemiologic pattern for EV 71 in This is a new epidemiologic pattern for EV 71 in Thailand. Careful monitoring of HFMD and Thailand. Careful monitoring of HFMD and pediatric cardiopulmonary failure cases is pediatric cardiopulmonary failure cases is needed.needed.
2626
Chronological Change of EV71 Chronological Change of EV71 Subgenogroups in West Pacific RegionSubgenogroups in West Pacific Region
((K.H. Lin et. al. K.H. Lin et. al. J. Med. Virol. 78J. Med. Virol. 78))CountriesCountries 8080 8686 9797 9898 9999 0000 0101 0202 0303 0404 0505
SingaporeSingapore -- -- B3,B3,B4B4
B3B3C1C1 B3B3 B4B4 B4B4 C1 C1
B4B4 -- -- --
MalaysiaMalaysia -- -- B3B3 C1C1 NoNo B4B4 C1C1 NoNo C1C1 C1 C1
B5B5 NoNo --
ThailandThailand -- -- -- -- -- -- -- C1C1 -- -- --
TaiwanTaiwan B1B1 B1B1 -- C2C2 B4B4 B4B4 B4B4 B4B4 B4B4 B4B4 C4C4 C4C4
JapanJapan-- --
B3 B3 B4 B4 C2C2
-- -- B4 B4 C2C2 C4C4 C4C4 --
ChinaChina -- -- C3C3 C4C4 -- C4C4 C4C4 C4C4 C4C4 C4C4 --
Australia, PerthAustralia, Perth -- -- -- -- B3 B3 C2C2 C1C1 NoNo NoNo
Pathogenesis of Enterovirus InfectionPathogenesis of Enterovirus Infection
Clinical Stage of Enterovirus 71Clinical Stage of Enterovirus 71 Stage I : Symptom onset stage Stage I : Symptom onset stage
(24-72 hrs)(24-72 hrs)– Fever , loss of appetite, oro-pharyngeal Fever , loss of appetite, oro-pharyngeal
symptoms, skin manifestation and coughsymptoms, skin manifestation and cough
Stage II : Symptom generalized Stage Stage II : Symptom generalized Stage (12-24 hrs )(12-24 hrs )
– Irritable, restlessness, unable to get into Irritable, restlessness, unable to get into sleep, abdominal distension, paralytic ileus, sleep, abdominal distension, paralytic ileus, vomiting, headache, photophobia, startle vomiting, headache, photophobia, startle responseresponse
Clinical Stage of Enterovirus 71Clinical Stage of Enterovirus 71 Stage III : Brainstem dysfunction Stage Stage III : Brainstem dysfunction Stage
( 12-24 hrs )( 12-24 hrs )– Generalized brainstem symptomsGeneralized brainstem symptoms– Apathic, dullness, myoclonic jerks, sleepy, Apathic, dullness, myoclonic jerks, sleepy,
drowsy, visual or auditory or vestibular drowsy, visual or auditory or vestibular hallucinationshallucinations
– Localized brainstem symptomsLocalized brainstem symptoms– Mono-/Hemi-/or General weakness, ataxia, Mono-/Hemi-/or General weakness, ataxia,
tension tremor, panic of unknown reason, tension tremor, panic of unknown reason, conjugated ocular disturbance, CN palsy conjugated ocular disturbance, CN palsy ( VI,VII,IX,X,XII)( VI,VII,IX,X,XII)
– Autonomic dysfunction symptomsAutonomic dysfunction symptoms– Tachycardia, cold sweating, poor peripheral Tachycardia, cold sweating, poor peripheral
circulation, HR > 160 bpmcirculation, HR > 160 bpm
Clinical Stage of Enterovirus 71Clinical Stage of Enterovirus 71
Stage IV : Deteriorating Stage Stage IV : Deteriorating Stage ( 6 – 12 hrs )( 6 – 12 hrs )
– Hypothermia, hemorrhagic cystitisHypothermia, hemorrhagic cystitis– Tachycardia > 200 bpmTachycardia > 200 bpm– Apnea, respiratory disturbance, Apnea, respiratory disturbance,
opsocloniaopsoclonia– Neurogenic shock, conscious Neurogenic shock, conscious
disturbancedisturbance
Clinical Stage of Enterovirus 71Clinical Stage of Enterovirus 71
Stage V : Terminal Stage Stage V : Terminal Stage ( 6-12 hrs )( 6-12 hrs )
– Cardiopulmonary failureCardiopulmonary failure– ARDSARDS– ComatoseComatose– ExpiredExpired
Timeline of Clinical Stage Timeline of Clinical Stage (Involved Brain Stem) (Involved Brain Stem)
3-5 days 1-3 days ½ - 1day ½ - 1 day ¼ - ½ day ½ day
Incubation period
Stage I Stage II Stage III Stage IV Stage V
Onset
The longest length of clinical course – 6 days
The shortest length of clinical course – < 3 days
3 4 5 5.5 6
1 1.5 2 2.25 2.75Infect
3333
Public Health ActionsPublic Health Actions• Established a working group of epidemiologists Established a working group of epidemiologists
and pediatricians aimed at studying clinical and and pediatricians aimed at studying clinical and epidemiological aspects of fatal EV71 infectionsepidemiological aspects of fatal EV71 infections
• Strengthened lab capacity for identifying Strengthened lab capacity for identifying enteroviral infections (12 new labs w/ PCR)enteroviral infections (12 new labs w/ PCR)
• Created new national surveillance system for Created new national surveillance system for pediatric cardiopulmonary failure and fatal pediatric cardiopulmonary failure and fatal HFMD cases in ThailandHFMD cases in Thailand
• Media campaign for educating public about Media campaign for educating public about HFMD and non-HFMD EV71 infection by TV, HFMD and non-HFMD EV71 infection by TV, newspaper and internetnewspaper and internet
3434
LimitationsLimitations
• No specimens available to confirm etiology No specimens available to confirm etiology in most cases, including most fatal casesin most cases, including most fatal cases
• Etiology determined in only 14/42 cases Etiology determined in only 14/42 cases (2/4 fatalities)(2/4 fatalities)
• Investigation delayed for almost 2 weeks Investigation delayed for almost 2 weeks after fatalities occurred; may have missed after fatalities occurred; may have missed non-fatal cases and overestimated CFRnon-fatal cases and overestimated CFR
3535
AcknowledgementAcknowledgementssNakhorn Ratchasima Health OfficeNakhorn Ratchasima Health OfficeMaharaj Nakhorn Ratchasima Regional Hospital Maharaj Nakhorn Ratchasima Regional Hospital Srikue Community HospitalSrikue Community HospitalNational Institute of Health, Department of Medical National Institute of Health, Department of Medical
Science, MOPHScience, MOPHDepartment of Microbiology, Siriraj Hospital and Department of Microbiology, Siriraj Hospital and
Faculty of Medicine, Mahidol University Faculty of Medicine, Mahidol University Thailand MoPH – US CDC Collaboration (TUC)Thailand MoPH – US CDC Collaboration (TUC)
** Travel Budget supported by IEIP, TUC** Travel Budget supported by IEIP, TUC
3636
Thank You for Your Kind Attention
3737
Notice for Dengue Lovers!Notice for Dengue Lovers!The Second International The Second International Conference on Dengue and Conference on Dengue and Dengue Hemorrhagic Fever 2008Dengue Hemorrhagic Fever 2008• Will be held at the Hilton Will be held at the Hilton PhuketPhuket Arcadia Arcadia
Resort & Spa, Karon Beach, Phuket, ThailandResort & Spa, Karon Beach, Phuket, Thailand• On October 15On October 15thth – 17 – 17thth , 2008 , 2008
Further information please visit Further information please visit www.dengue2008phuket.comwww.dengue2008phuket.com
3838
Viral Study Result among Viral Study Result among Fatal CasesFatal Cases
Viral StudyViral Study Case 1Case 1 Case 2Case 2 Case 3Case 3 Case 4Case 4
Enterovirus Enterovirus IsolationIsolation
No No specimen specimen EV71 EV71 No No
specimenspecimenNoNospecimenspecimen
Autopsy Autopsy Brainstem Brainstem InfectionInfection
Not Not DoneDone
NotNot Done Done
NotNot DoneDone
ElectronElectron MicroscopyMicroscopy
EV identified EV identified in Brainstemin Brainstem
Not Not DoneDone
NotNot Done Done
NotNot DoneDone
SummarySummary ConfirmConfirm ConfirmConfirm ProbableProbable ProbableProbable
3939
Seroprevalence of Anti-EV71 among Singaporean Child, 2005
Highly Susceptible
Age: 1 mo – 5 yr
4040
Reticular formation involvement autonomic dysfunctionDamage of some area of brain stem esp. medullary vasomotor center
Sympathetic over-stimulation
Excessive release hormonal of Cathecolamine & Cortisol
HT, Tachycardia, Sweating, Hyperglycemia
Pulmonary veins constriction
Inc. pulmonary capillary hydrostatic pressure
Pulmonary edema
Pathogenesis: “unclear”
4141
EV71EV71• In Taiwanese outbreak, cause of death was In Taiwanese outbreak, cause of death was
brainstem EV71 infection resulting in brainstem EV71 infection resulting in cardiopulmonary failurecardiopulmonary failure
• All 6 cases of fatal confirmed EV71 infection All 6 cases of fatal confirmed EV71 infection occurring in Thailand since 2006 have shown occurring in Thailand since 2006 have shown evidence of multiple indicators of brainstem evidence of multiple indicators of brainstem infection includinginfection including• Pulmonary edema/hemorrhagePulmonary edema/hemorrhage• HyperglycemiaHyperglycemia• TachycardiaTachycardia• Leukocytosis Leukocytosis
4242
Case 3 and Case 4Case 3 and Case 4
They had the indicators of brainstem They had the indicators of brainstem infection or damage resulting to infection or damage resulting to cardiopulmonary malfunction which cardiopulmonary malfunction which includingincluding1. Non-cardiogenic pulmonary edema1. Non-cardiogenic pulmonary edema2. Increased sympathetic activity2. Increased sympathetic activity
HyperglycemiaHyperglycemiaExtreme tachycardia with irregular patternExtreme tachycardia with irregular pattern
3. Leukocytosis3. Leukocytosis
4343
Situation of Fatal EV71 Infection in Situation of Fatal EV71 Infection in Thailand 2006Thailand 2006
In 2006, we found 15 cases of EV71 infection In 2006, we found 15 cases of EV71 infection with deathwith death– 8 cases8 cases presented with fever and acute pulmonary presented with fever and acute pulmonary
edema (non-cardiogenic) edema (non-cardiogenic) without HFMDwithout HFMD Of these 8 cases the laboratory confirmed for EV71 in 3 Of these 8 cases the laboratory confirmed for EV71 in 3 cases ( all other 2 cases specimen unavailable, 3 cases cases ( all other 2 cases specimen unavailable, 3 cases negative for any EV ) negative for any EV )
– 7 cases7 cases presented with fever and acute pulmonary presented with fever and acute pulmonary edema edema with HFMDwith HFMD
Of these 7 cases the laboratory confirmed for EV71 in 3 Of these 7 cases the laboratory confirmed for EV71 in 3 cases ( all other were no specimen available)cases ( all other were no specimen available)
4444
Viral Pathogen’s Structures Viral Pathogen’s Structures causing Brain Stem Infectioncausing Brain Stem Infection
PathogenPathogen StructuresStructuresEnterovirusesEnteroviruses ss-RNA, ss-RNA, non-envelopednon-enveloped, , 20-30 20-30 nm, nm,
IcosahedralIcosahedral, , mature in cytoplasmmature in cytoplasm FlavivirusesFlaviviruses ss-RNA, enveloped, 37-50 nm, ss-RNA, enveloped, 37-50 nm,
Icosahedral Icosahedral HerpesvirusesHerpesviruses ds-DNA, enveloped, 150-200 nm, ds-DNA, enveloped, 150-200 nm,
IcosahedralIcosahedralAdenovirusesAdenoviruses ds-DNA, enveloped, 60-90 nm, ds-DNA, enveloped, 60-90 nm,
IcosahedralIcosahedralRhabdovirusesRhabdoviruses RNA, enveloped, 180 nm, cylindricalRNA, enveloped, 180 nm, cylindrical